XML 91 R81.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Information (Tabulation of Business Segment Information Based on Current Segmentation) (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2025
Mar. 31, 2024
Segment Reporting Information [Line Items]        
Total Consolidated Revenue $ 466,055 $ 412,658 $ 1,331,184 $ 1,174,745
Total consolidated adjusted operating income 105,366 89,782 282,662 228,660
Restructuring expense (510) (473) (2,926) (1,217)
Business integration expense   (18,450) 0 (30,621)
Total consolidated intangible amortization expense (2,805) (8,286) (8,415) (28,296)
Litigation reserve     5,550 (18,500)
Asset impairments (6,442)   (6,442)  
Strategic advisory costs (5,100)   (5,100)  
Loss on assets held for sale       (647)
Debt modification costs   (848) (712) (848)
Total consolidated operating income 90,509 61,725 264,617 148,531
Interest expense (13,074) (16,560) (41,465) (48,910)
Other income, net 1,898 2,871 6,779 8,648
Total consolidated income from continuing operations before income taxes 79,333 48,036 229,931 108,269
Total consolidated depreciation expense 10,274 10,498 30,267 29,879
Chamberlain        
Segment Reporting Information [Line Items]        
Total Consolidated Revenue 192,592 170,338 541,508 466,487
Walden        
Segment Reporting Information [Line Items]        
Total Consolidated Revenue 178,418 150,607 511,237 439,023
Restructuring expense       776
Medical and Veterinary        
Segment Reporting Information [Line Items]        
Total Consolidated Revenue 95,045 91,713 278,439 269,235
Restructuring expense (121) (194) (236) (379)
Operating Segments | Chamberlain        
Segment Reporting Information [Line Items]        
Total Consolidated Revenue 192,592 170,338 541,508 466,487
Total consolidated adjusted operating income 47,493 43,349 117,628 97,313
Total consolidated depreciation expense 5,350 4,938 16,184 13,840
Operating Segments | Walden        
Segment Reporting Information [Line Items]        
Total Consolidated Revenue 178,418 150,607 511,237 439,023
Total consolidated adjusted operating income 47,999 31,871 136,794 93,141
Total consolidated intangible amortization expense (2,805) (8,286) (8,415) (28,296)
Total consolidated depreciation expense 1,951 1,835 5,428 5,735
Operating Segments | Medical and Veterinary        
Segment Reporting Information [Line Items]        
Total Consolidated Revenue 95,045 91,713 278,439 269,235
Total consolidated adjusted operating income 17,921 22,953 54,170 59,521
Total consolidated depreciation expense 2,785 3,033 8,098 8,897
Home Office        
Segment Reporting Information [Line Items]        
Total consolidated adjusted operating income (8,047) (8,391) (25,930) (21,315)
Total consolidated depreciation expense $ 188 $ 692 $ 557 $ 1,407